Zimmer Biomet (NYSE:ZBH) said today that it inked a 20-year collaboration with the Indo UK Institute of Health as a preferred orthopedic partner for the Medicity program. The partnership aims to improve access to affordable musculoskeletal healthcare for the people of India.
“Zimmer Biomet is proud to be chosen as a preferred orthopaedic partner for the IUIH Medicities program,” president & CEO David Dvorak said in prepared remarks. “This long-term commitment demonstrates an unprecedented level of partnership between a forward-looking healthcare provider and a leading musculoskeletal healthcare company, putting transformational patient care and exponential value creation within reach.”
According to the partnership, Zimmer Biomet will commit to an equity investment in UK Global Healthcare Limited, the parent company for IUIH. The Warsaw, Ind.-based company will also supply and distribute quality large joint implants, trauma products and small fixation devices for replacement surgery.
The company will also help establish the Zimmer Biomet Institute of India as a medical training and education facility. The long-term partnership could reduce the total cost of orthopedic care in India by 25%, according to Zimmer Biomet.
“At its 1-year anniversary, the IUIH Medicities Program is delighted to announce Zimmer Biomet as a preferred orthopedic partner for the next two decades,” IUIH CEO Dr. Ajay Gupta added. “IUIH shares Zimmer Biomet’s commitment to improve the quality of life for patients around the world. This partnership demonstrates a significant step toward achieving our vision to transform the delivery of quality healthcare and medical education services across India.”
The company joined Stryker (NYSE:SYK) as a member of the Medicity program. Last week, Stryker said it landed the 20-year collaboration with the IUIH.
The post Zimmer Biomet joins Indo UK Institute of Health’s Medicity program appeared first on MassDevice.
from MassDevice http://ift.tt/2gBdJy5
Cap comentari:
Publica un comentari a l'entrada